Cargando…
Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?
Several recent pharmacogenetic studies have investigated the variability in both outcome and toxicity in cisplatin-based therapies. These studies have focused on the genetic variability of therapeutic targets that could affect cisplatin response and toxicity in diverse type of cancer including lung,...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231946/ https://www.ncbi.nlm.nih.gov/pubmed/25452763 http://dx.doi.org/10.3389/fgene.2014.00391 |